Semaglutide studies: 1,194 papers with results
Page 21 of 24
- The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK.
Viljoen A · The European journal of health economics : HEPAC : health economics in prevention and care · 2023
Not a test of Semaglutide alone · 14 results
- Long- and Short-Term Cost-Effectiveness of Once-Weekly Semaglutide versus Dulaglutide for the Treatment of Type 2 Diabetes in China: A Hypothetical Modeling Exercise.
Hu Y · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
Not a test of Semaglutide alone · 14 results
- Use of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension : a systematic review.
Ognard J · The journal of headache and pain · 2025
Not a test of Semaglutide alone · 7 results
- Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study.
Aroda VR · The lancet. Diabetes & endocrinology · 2026
Not a test of Semaglutide alone · 13 results
- GLP-1 receptor agonist therapy before bariatric surgery: Effects on weight loss and body composition in clinical practice.
Gutiérrez-Medina S · Obesity research & clinical practice · 2026
Not a test of Semaglutide alone · 14 results
- Efficacy and Hypoglycaemia Outcomes With Once-Weekly IcoSema Versus Comparators in Individuals With Type 2 Diabetes by Kidney and Liver Function: A Post Hoc Analysis of the COMBINE 1-3 Trials.
Ji L · Diabetes, obesity & metabolism · 2026
Not a test of Semaglutide alone · 7 results
- Hyperdilute Radiesse Preserves Facial Volume in Glucagon-Like Peptide-1 Receptor Agonist Users Undergoing Rapid Weight Loss.
Durairaj KK · Aesthetic surgery journal. Open forum · 2025
Not a test of Semaglutide alone · 7 results
- Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction.
Ibrahim R · Journal of the American Heart Association · 2025
Not a test of Semaglutide alone · 14 results
- Efficacy and safety of GLP-1 receptor agonists for adolescents and children with obesity: a meta-analysis of randomized controlled trials.
Chen Q · BMC endocrine disorders · 2026
Not a test of Semaglutide alone · 14 results
- Cancer risk of glucagon-like peptide-1 receptor agonists for obesity: comparison with bariatric surgery and other weight-loss drugs.
Bitar ER · Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2026
Not a test of Semaglutide alone · 14 results
- Nutritional Deficiencies, Complications, and Nutrition Therapy/Counseling in Pediatric Patients Using GLP-1 Receptor Agonists.
Kerr KW · Childhood obesity (Print) · 2026
Not a test of Semaglutide alone · 21 results
- Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.
Garvey WT · The New England journal of medicine · 2025
Not a test of Semaglutide alone · 12 results
- Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis.
Zaccardi F · Annals of internal medicine · 2016
Not a test of Semaglutide alone · 6 results
- Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada.
Johansen P · PharmacoEconomics - open · 2019
Not a test of Semaglutide alone · 6 results
- Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in Adults: A Systematic Review and Meta-Analysis.
Alexander GC · JAMA internal medicine · 2026
Not a test of Semaglutide alone · 12 results
- Association of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and neurogenesis: a systematic review.
Au HCT · Acta neuropsychiatrica · 2025
Not a test of Semaglutide alone · 12 results
- Evaluating the Rates of Pancreatitis and Pancreatic Cancer Among GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Wen J · Endocrinology, diabetes & metabolism · 2025
Not a test of Semaglutide alone · 18 results
- Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China.
Ruan Z · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2022
Not a test of Semaglutide alone · 12 results
- Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis.
Igarashi A · Advances in therapy · 2020
Not a test of Semaglutide alone · 12 results
- The potential role of GLP-1 receptor agonists in substance use disorders - a systematic review.
Völker KM · Frontiers in pharmacology · 2025
Not a test of Semaglutide alone · 12 results
- Cost-Utility Analysis of Once-Weekly Semaglutide, Dulaglutide, and Exenatide for Type 2 Diabetes Patients Receiving Metformin-Based Background Therapy in China.
Hu S · Frontiers in pharmacology · 2022
Not a test of Semaglutide alone · 13 results
- GLP-1RA versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: An updated meta-analysis of randomized controlled trials.
Duhan S · International journal of cardiology · 2025
Not a test of Semaglutide alone · 12 results
- Dosing Patterns of Dulaglutide and Semaglutide in Patients with Type 2 Diabetes in the United Kingdom and Germany: A Retrospective Cohort Study.
Barrett A · Advances in therapy · 2023
Not a test of Semaglutide alone · 10 results
- Impact of GLP-1 Analogue Therapy on Gastrointestinal Outcomes in Patients with Irritable Bowel Syndrome: A Real-World TriNetX Analysis.
Khan SA · Digestive diseases and sciences · 2026
Not a test of Semaglutide alone · 24 results
- Effects of GLP-1 Receptor Agonist Therapy on Eating Disorder Risk and Psychological Distress in Adults With Class 3 Obesity.
Maynard S · The International journal of eating disorders · 2026
Not a test of Semaglutide alone · 6 results
- Association Between Glucagon-Like Peptide-1 Receptor Agonists and Suicidality: A Systematic Review.
Chan TH · Diabetes, obesity & metabolism · 2026
Not a test of Semaglutide alone · 12 results
- Complete radiologic and clinical reversal of lumbar spinal epidural lipomatosis via GLP-1 agonist.
Wurm LM · Journal of surgical case reports · 2026
Not a test of Semaglutide alone · 6 results
- Glucagon-like peptide-1 agonists in children with obesity and type 2 diabetes. an umbrella review.
Mirghani H · Frontiers in endocrinology · 2026
Not a test of Semaglutide alone · 18 results
- Cagrilintide and CagriSema for weight reduction and metabolic risk modification in overweight or obesity: a systematic review and meta-analysis.
Rao H · Journal of diabetes and metabolic disorders · 2026
Not a test of Semaglutide alone · 16 results
- Cost-effectiveness of semaglutide versus dulaglutide for Type 2 Diabetes in China: A Markov Model analysis.
Chen Q · PloS one · 2026
Not a test of Semaglutide alone · 9 results
- Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes : A Target Trial Emulation.
Lipska KJ · Annals of internal medicine · 2026
Not a test of Semaglutide alone · 16 results
- Amylin-based obesity therapy: a meta-analysis of Cagrilintide and CagriSema versus placebo.
Yaseen M · Annals of medicine and surgery (2012) · 2026
Not a test of Semaglutide alone · 15 results
- Weight Regain Trajectories After Discontinuation of Semaglutide or Tirzepatide: A Reconstructed Aggregate-Data Bayesian Longitudinal Meta-Analysis.
Kow CS · Endocrinology, diabetes & metabolism · 2026
Not a test of Semaglutide alone · 14 results
- Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis.
Ayoub M · Journal of clinical medicine · 2025
Not a test of Semaglutide alone · 15 results
- Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes - A systematic review and meta-analysis.
Yoshida Y · Journal of diabetes and its complications · 2022
Not a test of Semaglutide alone · 10 results
- Evaluation of the long-term cost-effectiveness of once-weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK.
Viljoen A · Diabetes, obesity & metabolism · 2019
Not a test of Semaglutide alone · 5 results
- Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials.
Monami M · International journal of cardiology · 2017
Not a test of Semaglutide alone · 5 results
- Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials.
Kang YM · Diabetes & metabolism journal · 2019
Not a test of Semaglutide alone · 10 results
- Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) on Weight Loss Following Bariatric Treatment.
Kramer CK · The Journal of clinical endocrinology and metabolism · 2024
Not a test of Semaglutide alone · 10 results
- Cost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden.
Ericsson Å · Journal of medical economics · 2019
Not a test of Semaglutide alone · 7 results
- Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trial.
Billings LK · The lancet. Diabetes & endocrinology · 2025
Not a test of Semaglutide alone · 5 results
- Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States.
Wilkinson L · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2018
Not a test of Semaglutide alone · 10 results
- Long-acting PYY3 -36 analogue with semaglutide for obesity: from preclinical assessment through randomized clinical studies.
Wulff BS · Obesity (Silver Spring, Md.) · 2025
Not a test of Semaglutide alone · 5 results
- Non-Arteritic Anterior Ischemic Optic Neuropathy in an Otherwise Healthy Young Adult Patient Treated with Liraglutide and Semaglutide for Weight Loss: A Cautionary Tale.
Lixi F · International medical case reports journal · 2025
Not a test of Semaglutide alone · 11 results
- Cost-utility analysis of semaglutide for type 2 diabetes after its addition to the National Medical Insurance System in China.
Hu S · Diabetes, obesity & metabolism · 2023
Not a test of Semaglutide alone · 10 results
- A Systematic Review Identifying Critical Evidence Gaps in Reporting Dietary Change in Randomized Controlled Trials Prescribing Liraglutide, Semaglutide, or Tirzepatide.
Jansson AK · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
Not a test of Semaglutide alone · 15 results
- Expectations and Outcomes From Glucagon-Like Peptide-1 Receptor Agonists As Adjunct Treatment for Type 1 Diabetes - Case Presentations.
Seetharaman S · Journal of diabetes science and technology · 2025
Not a test of Semaglutide alone · 10 results
- Predictive factors of body weight loss in patients with type 2 diabetes treated with GLP-1 receptor agonists: a 52-week prospective real-life study.
Vozza A · Frontiers in endocrinology · 2025
Not a test of Semaglutide alone · 5 results
- CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1.
Verma S · Hypertension (Dallas, Tex. : 1979) · 2026
Not a test of Semaglutide alone · 10 results
- Real-World Alcohol Use Disorder Outcomes in Patients With Concurrent Metabolic Dysfunction: GLP-1 Receptor Agonists Versus FDA-Approved AUD Medications.
Gougol A · Alimentary pharmacology & therapeutics · 2026
Not a test of Semaglutide alone · 10 results